DOI QR코드

DOI QR Code

Health-Related Quality of Life and Nutritional Status Are Related to Dietary Magnesium Intake in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

  • Afsane Ahmadi (Research Center for Health Sciences, Institute of Health, Shiraz University of Medical Sciences) ;
  • Mohammad Hassan Eftekhari (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences) ;
  • Zohreh Mazloom (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences) ;
  • Masoom Masoompour (Non-communicable Disease Research Center, Shiraz University of Medical Sciences) ;
  • Mohammad Fararooei (Department of Epidemiology, School of Health, Shiraz University of Medical Sciences) ;
  • Morteza Zare (Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences) ;
  • Najmeh Hejazi (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences)
  • Received : 2021.11.07
  • Accepted : 2022.01.10
  • Published : 2022.01.31

Abstract

An insufficient intake of magnesium may be associated with the development of chronic obstructive pulmonary disease (COPD). We aimed to determine the relationship between health related quality of life (QoL), anthropometric indices and nutritional status with dietary magnesium intake in COPD patients. Sixty-one COPD patients participated in this cross-sectional study. QoL and nutritional status were assessed. Furthermore, body composition, calf circumference, and muscle strength were measured; equations were used to calculate fat-free mass index, body mass index, and muscle mass value. Dietary magnesium intake was assessed by three 24-hours recalls and magnesium intake was categorized as ≤ 188.08 mg/day (A group) and > 188.08 mg/day (B group). The χ2, independent-sample t-test and Mann-Whitney test were used for statistical analysis. The p values less than 0.05 were considered significant. Of QoL assessments the total and impact mean scores of St. George's respiratory questionnaire in the B group were significantly lower than the means of the A group (p value = 0.007 and 0.005, respectively). The instrumental activity of daily living score was significantly improved in patients with higher consumption of dietary magnesium (p = 0.02). Participants had a significantly lower mean score of patient-generated subjective global assessment in the B group compared to the A group (p = 0.003). Higher intake of dietary magnesium can lead to improve QoL and nutrition status.

Keywords

Acknowledgement

The authors thank the cooperation of the participating patients. This study was extracted from Afsane Ahmadi's PhD dissertation.

References

  1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
  2. Ko FWS, Hui DSC, Lai CKW. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis 2008;12:713-7.
  3. Yang K, Wu Y, Chen D, Liu S, Chen R. The impact of lung function on extra-pulmonary diseases and all-cause mortality in US adult population with and without COPD. Clin Epidemiol 2020;12:997-1005.
  4. Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol 2017;70:128-34.
  5. World Health Organization. Chronic respiratory diseases, burden of chronic obstructive pulmonary disease. Geneva: World Health Organization; 2015. 
  6. Choi HS, Yang DW, Rhee CK, Yoon HK, Lee JH, Lim SY, Kim YI, Yoo KH, Hwang YI, Lee SH, Park YB. The health-related quality-of-life of chronic obstructive pulmonary disease patients and disease-related indirect burdens. Korean J Intern Med (Korean Assoc Intern Med) 2020;35:1136-44.
  7. Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, Chen N, Zhang L, Wu H, Zhao J. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health 2012;12:287.
  8. Xiao T, Wu K, Chen Y, Qiu H, Ruan X, Wang N, Zhao Q, Fu C. Quality of life and its associated factors for mild chronic obstructive pulmonary disease patients of urban community settings. Ann Palliat Med 2020;9:1420-30.
  9. Long H, Howells K, Peters S, Blakemore A. Does health coaching improve health-related quality of life and reduce hospital admissions in people with chronic obstructive pulmonary disease? A systematic review and meta-analysis. Br J Health Psychol 2019;24:515-46.
  10. Hancu A. Nutritional status as a risk factor in COPD. Maedica (Bucur) 2019;14:140-3. 
  11. Gea J, Sancho-Munoz A, Chalela R. Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. J Thorac Dis 2018;10:S1332-54.
  12. Gumus A, Haziroglu M, Gunes Y. Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study. Pulm Med 2014;2014:329476.
  13. Barbagallo M, Gupta RK, Dominguez LJ, Resnick LM. Cellular ionic alterations with age: relation to hypertension and diabetes. J Am Geriatr Soc 2000;48:1111-6.
  14. Veronese N, Zanforlini BM, Manzato E, Sergi G. Magnesium and healthy aging. Magnes Res 2015;28:112-5.
  15. Correa F, Farah CS, Salinas RK. Mg2+ ions bind at the C-terminal region of skeletal muscle α-tropomyosin. Biopolymers 2009;91:583-90.
  16. Grabarek Z. Insights into modulation of calcium signaling by magnesium in calmodulin, troponin C and related EF-hand proteins. Biochim Biophys Acta 2011;1813:913-21.
  17. Ye M, Li Q, Xiao L, Zheng Z. Serum magnesium and fractional exhaled nitric oxide in relation to the severity in asthma-chronic obstructive pulmonary disease overlap. Biol Trace Elem Res 2021;199:1771-7.
  18. Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res 2009;22:235-46.
  19. Ahmadi A, Mazloom Z, Eftekhari MH, Masoompour SM, Fararouei M, Eskandari MH, Mehrabi S, Zare M, Sohrabi Z. Muscle mass and function are related to respiratory function in chronic obstructive pulmonary disease. Med J Islam Repub Iran 2021;35:34.
  20. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis 2008;5:205-9.
  21. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101.
  22. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W, Muscaritoli M, Pison C, Rutten-van Molken M, Slinde F, Steiner MC, Tkacova R, Singh SJ. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014;44:1504-20.
  23. Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW, Hill CL. Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 2011;4:127.
  24. Bauer J, Egan E, Clavarino A. The scored patient-generated subjective global assessment is an effective nutrition assessment tool in subjects with chronic obstructive pulmonary disease. E Spen Eur E J Clin Nutr Metab 2011;6:e27-30.
  25. Schroder H, Covas MI, Marrugat J, Vila J, Pena A, Alcantara M, Masia R. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr 2001;20:429-37.
  26. Ahmadi A, Eftekhari MH, Mazloom Z, Masoompour M, Fararooei M, Eskandari MH, Mehrabi S, Bedeltavana A, Famouri M, Zare M, Nasimi N, Sohrabi Z. Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial. Respir Res 2020;21:216.
  27. Bakas T, McLennon SM, Carpenter JS, Buelow JM, Otte JL, Hanna KM, Ellett ML, Hadler KA, Welch JL. Systematic review of health-related quality of life models. Health Qual Life Outcomes 2012;10:134. 
  28. Noah L, Dye L, Bois De Fer B, Mazur A, Pickering G, Pouteau E. Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: post-hoc analysis of a randomised controlled trial. Stress Health 2021;37:1000-9.
  29. Kazaks AG, Uriu-Adams JY, Albertson TE, Shenoy SF, Stern JS. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma 2010;47:83-92.
  30. Al Alawi AM, Majoni SW, Falhammar H. Magnesium and human health: perspectives and research directions. Int J Endocrinol 2018;2018:9041694.
  31. Zanforlini BM, Ceolin C, Trevisan C, Alessi A, Seccia DM, Noale M, Maggi S, Guarnieri G, Vianello A, Sergi G. Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients. Aging Clin Exp Res. Forthcoming 2021.
  32. Hosseini SA, Fathi N, Tavakkol H, Yadollahpour A. Investigating the effects of oral magnesium citrate supplement on lung function, magnesium level and interlukine-17 in patients with asthma. Int J Pharm Res Allied Sci 2016;5:86-92. 
  33. Schols A, Broekhuizen R, Scheepers CW, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease: Am J Clin Nutr 2005 Jul;82(1):53-9. Respir Medicine COPD Update 2005;1:69-70.
  34. Passey SL, Hansen MJ, Bozinovski S, McDonald CF, Holland AE, Vlahos R. Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease. Pharmacol Ther 2016;166:56-70.
  35. Moslehi N, Vafa M, Sarrafzadeh J, Rahimi-Foroushani A. Does magnesium supplementation improve body composition and muscle strength in middle-aged overweight women? A double-blind, placebo-controlled, randomized clinical trial. Biol Trace Elem Res 2013;153:111-8.
  36. Welch AA, Kelaiditi E, Jennings A, Steves CJ, Spector TD, MacGregor A. Dietary magnesium is positively associated with skeletal muscle power and indices of muscle mass and may attenuate the association between circulating C-reactive protein and muscle mass in women. J Bone Miner Res 2016;31:317-25.
  37. Beaudart C, Locquet M, Touvier M, Reginster JY, Bruyere O. Association between dietary nutrient intake and sarcopenia in the SarcoPhAge study. Aging Clin Exp Res 2019;31:815-24.
  38. Gohari-Kahou M, Darroudi S, Saberi-Karimian M, Parizadeh SM, Asadi Z, Javandoost A, Safarian M, Mouhebati M, Ebrahimi M, Ferns GA, Kazerani HR, Ghayour-Mobarhan M. The association between serum and dietary magnesium with cardiovascular disease risk factors in Iranian adults with metabolic syndrome. Transl Metab Syndr Res 2020;3:42-8.
  39. Gedmantaite A, Celis-Morales CA, Ho F, Pell JP, Ratkevicius A, Gray SR. Associations between diet and handgrip strength: a cross-sectional study from UK Biobank. Mech Ageing Dev 2020;189:111269.
  40. Setaro L, Santos-Silva PR, Nakano EY, Sales CH, Nunes N, Greve JM, Colli C. Magnesium status and the physical performance of volleyball players: effects of magnesium supplementation. J Sports Sci 2014;32:438-45.
  41. Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, Simonsick EM, Ferrucci L. Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr 2006;84:419-26.
  42. Ter Borg S, de Groot LC, Mijnarends DM, de Vries JH, Verlaan S, Meijboom S, Luiking YC, Schols JM. Differences in nutrient intake and biochemical nutrient status between sarcopenic and nonsarcopenic older adults-results from the Maastricht Sarcopenia Study. J Am Med Dir Assoc 2016;17:393-401.
  43. Verlaan S, Aspray TJ, Bauer JM, Cederholm T, Hemsworth J, Hill TR, McPhee JS, Piasecki M, Seal C, Sieber CC, Ter Borg S, Wijers SL, Brandt K. Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: a case-control study. Clin Nutr 2017;36:267-74.
  44. Lukaski HC. Vitamin and mineral status: effects on physical performance. Nutrition 2004;20:632-44.
  45. Kheyruri F, Sarrafzadeh J, Hosseini AF, Abiri B, Vafa M. Randomized study of the effects of vitamin D and magnesium Co-supplementation on Muscle strength and function, body composition, and inflammation in vitamin D-deficient middle-aged women. Biol Trace Elem Res 2021;199:2523-34.
  46. Erem S, Atfi A, Razzaque MS. Anabolic effects of vitamin D and magnesium in aging bone. J Steroid Biochem Mol Biol 2019;193:105400.
  47. Wolf FI, Cittadini A. Chemistry and biochemistry of magnesium. Mol Aspects Med 2003;24:3-9.
  48. Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, Nair KS. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A 2005;102:5618-23.
  49. Lim S, Lam DC, Muttalif AR, Yunus F, Wongtim S, Lan TT, Shetty V, Chu R, Zheng J, Perng DW, de Guia T. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med 2015;14:4.
  50. Ingadottir AR, Beck AM, Baldwin C, Weekes CE, Geirsdottir OG, Ramel A, Gislason T, Gunnarsdottir I. Oral nutrition supplements and between-meal snacks for nutrition therapy in patients with COPD identified as at nutritional risk: a randomised feasibility trial. BMJ Open Respir Res 2019;6:e000349.
  51. Nichols BL, Alvarado J, Hazlewood CF, Viteri F. Magnesium supplementation in protein-calorie malnutrition. Am J Clin Nutr 1978;31:176-88.
  52. Fein P, Suda V, Borawsky C, Kapupara H, Butikis A, Matza B, Chattopadhyay J, Avra MM. Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients. Adv Perit Dial 2010;26:112-5.